Zentrela Inc. is a Canadian neurotechnology company revolutionizing cannabis research with the first scientific method to measure psychoactive effects. Using its proprietary Cognalyzer platform, Zentrela analyzes EEG data with machine learning to deliver accurate insights. By conducting large-scale observational studies, the company aims to set the global standard for measuring cannabis effects and building the largest scientific database of consumer cannabis experiences.